These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 33398966)

  • 1. [Progress in lentiviral vector-mediated gene therapy for Alzheimer's disease and Parkinson's disease].
    Xu D; Liu L; Lang M
    Sheng Wu Gong Cheng Xue Bao; 2020 Dec; 36(12):2707-2718. PubMed ID: 33398966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene therapy for Parkinson's and Alzheimer's diseases: from the bench to clinical trials.
    Nobre RJ; Almeida LP
    Curr Pharm Des; 2011; 17(31):3434-45. PubMed ID: 21902665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-replacement and gene-therapy strategies for Parkinson's and Alzheimer's disease.
    Korecka JA; Verhaagen J; Hol EM
    Regen Med; 2007 Jul; 2(4):425-46. PubMed ID: 17635050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Age-Related Neurodegenerative Diseases by AAV-Mediated Gene Therapy.
    Cagin U
    Adv Exp Med Biol; 2021; 1286():213-223. PubMed ID: 33725356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in the Application of Induced Pluripotent Stem Cells in Alzheimer's Disease and Parkinson's Disease.
    Xu Y; Wang S; Zhu P
    Curr Stem Cell Res Ther; 2023; 18(2):154-162. PubMed ID: 35473516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Links between COVID-19 and Parkinson's disease/Alzheimer's disease: reciprocal impacts, medical care strategies and underlying mechanisms.
    Huang P; Zhang LY; Tan YY; Chen SD
    Transl Neurodegener; 2023 Jan; 12(1):5. PubMed ID: 36717892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying the Association Between Alzheimer's Disease and Parkinson's Disease Using Genome-Wide Association Studies and Protein-Protein Interaction Network.
    Liu G; Bao X; Jiang Y; Liao M; Jiang Q; Feng R; Zhang L; Ma G; Chen Z; Wang G; Wang R; Zhao B; Li K
    Mol Neurobiol; 2015 Dec; 52(3):1629-1636. PubMed ID: 25370933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding Epigenetic Alterations in Alzheimer's and Parkinson's Disease: Towards Targeted Biomarkers and Therapies.
    Ciceri F; Rotllant D; Maes T
    Curr Pharm Des; 2017; 23(5):839-857. PubMed ID: 28120717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Exosomes in the Pathogenesis and Theranostic of Alzheimer's Disease and Parkinson's Disease.
    He A; Wang M; Li X; Chen H; Lim K; Lu L; Zhang C
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision medicine: Clarity for the clinical and biological complexity of Alzheimer's and Parkinson's diseases.
    Montine TJ; Montine KS
    J Exp Med; 2015 May; 212(5):601-5. PubMed ID: 25941321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurodegeneration enters the era of functional genomics.
    Aguzzi A; Kampmann M
    Science; 2023 Sep; 381(6662):eadk5693. PubMed ID: 37676963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidisciplinary perspectives for Alzheimer's and Parkinson's diseases: hydrogels for protein delivery and cell-based drug delivery as therapeutic strategies.
    Giordano C; Albani D; Gloria A; Tunesi M; Batelli S; Russo T; Forloni G; Ambrosio L; Cigada A
    Int J Artif Organs; 2009 Dec; 32(12):836-50. PubMed ID: 20037888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary study to identify CXCR4 inhibitors as potential therapeutic agents for Alzheimer's and Parkinson's diseases.
    Tripathi R; Kumar P
    Integr Biol (Camb); 2023 Apr; 15():. PubMed ID: 37635325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic networks in Parkinson's and Alzheimer's disease.
    Kelly J; Moyeed R; Carroll C; Luo S; Li X
    Aging (Albany NY); 2020 Mar; 12(6):5221-5243. PubMed ID: 32205467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The apolipoprotein E epsilon 4 allele in Parkinson's disease with Alzheimer lesions.
    Egensperger R; Bancher C; Kösel S; Jellinger K; Mehraein P; Graeber MB
    Biochem Biophys Res Commun; 1996 Jul; 224(2):484-6. PubMed ID: 8702415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neural regeneration therapies for Alzheimer's and Parkinson's disease-related disorders.
    Reddy AP; Ravichandran J; Carkaci-Salli N
    Biochim Biophys Acta Mol Basis Dis; 2020 Apr; 1866(4):165506. PubMed ID: 31276770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacoepigenomic Interventions as Novel Potential Treatments for Alzheimer's and Parkinson's Diseases.
    Teijido O; Cacabelos R
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30332838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease and Parkinson's disease genome-wide association study top hits and risk of Parkinson's disease in Korean population.
    Chung SJ; Jung Y; Hong M; Kim MJ; You S; Kim YJ; Kim J; Song K
    Neurobiol Aging; 2013 Nov; 34(11):2695.e1-7. PubMed ID: 23820587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of gene therapy in major brain diseases].
    Fan L; Jiang XG
    Yao Xue Xue Bao; 2010 Sep; 45(9):1095-102. PubMed ID: 21351564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.